Lyme disease is a vector-borne infectious disease that spreads primarily by the bite of a tick (also known as Ixodes scapularis). It is quite a common disease, and poses a huge economic burden to global healthcare.
DelveInsight adds another insightful newsletter to its series to focus on common vector-borne disease that are prevalent in developed countries and are expanding to other parts. Get a brief picture of the disease, its symptoms, signs, causes and diagnosis. It becomes necessary to spread awareness about the diseases, as it helps in timely diagnosis thereby, improving treatment output.
Know more about the Lyme disease treatment landscape, and unmet needs that the scientific community and pharmaceutical companies are trying to meet. Steal a look at the Lyme disease pipeline and emerging therapies, deals & tie-ups, ongoing clinical trials as well as recent happenings on the research front in the Lyme disease market domain.
Get access to our newsletter by filling up a simple form towards your tight.
Subscribe to our newsletter series for more such insights and analysis.
Stay tuned for more!
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Current Treatment approaches
- Unmet needs
- Key Companies
- Emerging therapies
- Ongoing clinical trials
- Collaborations and deals in the domain
- News Flash
- R&D in the field
- Market insights
- Support from International organizations